Sort
166,118 grants matching “stem cells”
In vivo CRISPR engineering of B cells to produce anti-HIV broadly neutralizing antibodies using novel nanoparticles
$830,363Jennifer Eileen Adair · Univ Of Massachusetts Med Sch Worcester · R01 · FY2025 · AI
Microglia targeted interventions in prodromal Alzheimer's disease stage
$830,339Julia Tcw · Boston University Medical Campus · R01 · FY2023 · AG
Gene Therapy Basic Research to Treat Inherited Primary Immune Deficiencies
$830,307Harry L Malech · National Institute Of Allergy And Infectious Diseases · ZIA · FY2018 · AI
Base editing and prime editing for sickle cell disease
$830,254Mitchell J Weiss · St. Jude Children'S Research Hospital · R01 · FY2025 · HL
Identification and eradication of HIV tissue reservoirs in a relevant animal mode
$830,244Binhua Ling · Tulane University Of Louisiana · R01 · FY2011 · AI
Human Genes that Influence HIV-1 Replication, Pathogenesis, and Immunity in IVDUs
$830,209Jeremy Luban · Univ Of Massachusetts Med Sch Worcester · DP1 · FY2012 · DA
Children's Oncology Group Statistics and Data Center
$830,139Todd A Alonzo · Public Health Institute · U10 · FY2020 · CA
Center for Iron and Heme Disorders (CIHD)
$830,063John Dearborn Phillips · University Of Utah · U54 · FY2016 · DK
CAREER: Glycosylation as a primary contributor to cell fate-specific membrane capacitance
$830,000Lisa A Flanagan · University Of California-Irvine · · FY2013 · BIO
NATHAN SHOCK AGING CENTER
$829,990University Of Texas Hlth Sci Ctr San Ant · P30 · FY2002 · AG
Role of a novel risk loci HAVCR2 of late-onset Alzheimer's disease in the regulation of microglial response in neurodegeneration
$829,912Vijay K Kuchroo · Brigham And Women'S Hospital · R01 · FY2024 · AG
Disease-Specific Integrated Microphysiological Human Tissue Models
$829,891Kevin E Healy · University Of California Berkeley · UH3 · FY2014 · TR
The wandering nerve: gateway to boost Alzheimer's disease related cognitive performance
$829,794Heidi Irma Jacobs · Massachusetts General Hospital · R01 · FY2024 · AG
Biophotonics
$829,707George Patterson · National Institute Of Biomedical Imaging And Bioengineering · ZIA · FY2011 · EB
MEKK3 signaling in hemogenic endothelium
$829,654Mark L Kahn · University Of Pennsylvania · R01 · FY2018 · HL
MUC1-C is a Target for Reversing Immune Evasion and Resistance to Immunotherapies
$829,650Donald W. Kufe · Dana-Farber Cancer Inst · U01 · FY2019 · CA
MUC1-C is a Target for Reversing Immune Evasion and Resistance to Immunotherapies
$829,650Donald W. Kufe · Dana-Farber Cancer Inst · U01 · FY2018 · CA
MUC1-C is a Target for Reversing Immune Evasion and Resistance to Immunotherapies
$829,650Donald W. Kufe · Dana-Farber Cancer Inst · U01 · FY2022 · CA
MUC1-C is a Target for Reversing Immune Evasion and Resistance to Immunotherapies
$829,650Donald W. Kufe · Dana-Farber Cancer Inst · U01 · FY2021 · CA
MUC1-C is a Target for Reversing Immune Evasion and Resistance to Immunotherapies
$829,650Donald W. Kufe · Dana-Farber Cancer Inst · U01 · FY2020 · CA
Cancer and Leukemia Group B - Leukemia Correlative Sciences
$829,642Guido Marcucci · Ohio State University · U10 · FY2010 · CA
A Treatment Paradigm for Femoracetabular Impingement (FAI)
$829,606Bradley T Estes · Cytex Therapeutics Inc. · R44 · FY2020 · AR
Regulation of CTCF Functions and Target Sites by Cancer/Testis-specific CTCF Like BORIS Factor
$829,516Victor Lobanenkov · National Institute Of Allergy And Infectious Diseases · ZIA · FY2021 · AI
Tracking the origin of tau pathology
$829,487Heidi Irma Jacobs · Massachusetts General Hospital · R01 · FY2021 · AG
Discovery, Biology and Risk of Inherited Variants in Glioma
$829,381Melissa L Bondy · Stanford University · R01 · FY2023 · CA